Company Filing History:
Years Active: 2023
Title: Anthony Daniyan: Innovator in Immunotherapy
Introduction
Anthony Daniyan is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of immunotherapy, particularly in enhancing the immune response against cancers and pathogens. His innovative work has the potential to transform treatment methodologies in oncology.
Latest Patents
Anthony Daniyan holds a patent for "IL-36 secreting immunoresponsive cells and uses thereof." This patent outlines methods and compositions designed to enhance the immune response toward cancers and pathogens. The invention involves immunoresponsive cells that comprise an antigen-recognizing receptor, such as a chimeric antigen receptor (CAR) or a T cell receptor (TCR), which express an increased level of IL-36. The engineered immunoresponsive cells are antigen-directed and exhibit enhanced immune-activating properties, making them a promising avenue for cancer treatment.
Career Highlights
Anthony Daniyan is affiliated with the Memorial Sloan Kettering Cancer Center, where he works alongside leading experts in the field. His research focuses on developing innovative therapies that leverage the body's immune system to combat cancer more effectively. His dedication to advancing cancer treatment has positioned him as a key figure in immunotherapy research.
Collaborations
Anthony collaborates with Renier J Brentjens, a fellow researcher at Memorial Sloan Kettering Cancer Center. Their combined expertise contributes to the development of cutting-edge immunotherapeutic strategies.
Conclusion
Anthony Daniyan's work in immunotherapy exemplifies the potential of innovative approaches to enhance cancer treatment. His patent on IL-36 secreting immunoresponsive cells represents a significant advancement in the field, showcasing his commitment to improving patient outcomes.